Moderna Unusual Options Activity

Someone with a lot of money to spend has taken a bearish stance on Moderna MRNA.

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with MRNA, it often means somebody knows something is about to happen.

So how do we know what this whale just did?

Today, Benzinga's options scanner spotted 13 uncommon options trades for Moderna.

This isn't normal.

The overall sentiment of these big-money traders is split between 46% bullish and 53%, bearish.

Out of all of the special options we uncovered, 5 are puts, for a total amount of $187,443, and 8 are calls, for a total amount of $388,078.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $150.0 for Moderna over the last 3 months.

Volume & Open Interest Development

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 888.92 with a total volume of 1,147.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $65.0 to $150.0 over the last 30 days.

Moderna Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Where Is Moderna Standing Right Now?

• With a volume of 1,350,793, the price of MRNA is down -2.01% at $110.39.
• RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
• Next earnings are expected to be released in 69 days.

What The Experts Say On Moderna:

• Deutsche Bank downgraded its action to Hold with a price target of $125
• RBC Capital has decided to maintain their Outperform rating on Moderna, which currently sits at a price target of $190.
• B of A Securities has decided to maintain their Neutral rating on Moderna, which currently sits at a price target of $150.
• TD Cowen downgraded its action to Market Perform with a price target of $125
• Morgan Stanley has decided to maintain their Equal-Weight rating on Moderna, which currently sits at a price target of $123.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.